BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Immune tolerance offers a transformative approach to autoimmun
 e diseases treatment and holds the power to modify the course of disease 
 progression and significantly improve the quality of life for patients.\n
 \nFor 7 years\, the 8th Antigen-Specific Immune Tolerance Summit has been
  at the forefront of innovative and novel approaches to immunology and in
 flammation and facilitated the development of new industry connections\, 
 research partnerships and seed investment across the immune tolerance fie
 ld.\n\nIn 2025\, this highly anticipated meeting will delve further into 
 the complex reality of inducing immune tolerance as the landscape evolves
  with Diamyd\, Annokion\, COUR and more being the custodians of rapidly p
 rogressing clinical tirals.\n\nFrom antigen selection\, to establishing b
 iomarkers of tolerance to brand-new clinical readouts\, join 120+ autoimm
 une\, immunology and inflammation experts at this timely and comprehensiv
 e network to continue to drive the momentum in the field.\n\nWith new com
 panies\, new antigens\, and new disease targets\, you can't miss this opp
 ortunity to capitalize on the wealth of opportunities in antigen-specific
  immune tolerance drug development and contribute to the transformation o
 f autoimmune disease treatment.\n\nURLs:Website:&nbsp\;https://go.evvnt.c
 om/2706824-0?pid=185Tickets:&nbsp\;https://go.evvnt.com/2706824-1?pid=185
 Brochure:&nbsp\;https://go.evvnt.com/2706824-2?pid=185\n\nPrices:Drug Dev
 eloper - Conference + Pre-Conference Seminar Day: USD 5046.00\,Academic -
  Conference + Pre-Conference Seminar Day: USD 4346.00\,Solution Provider 
 - Conference + Pre-Conference Seminar Day: USD 5746.00\,Drug Developer - 
 Conference Only: USD 3099.00\,Academic - Conference Only: USD 2699.00\,So
 lution Provider - Conference Only: USD 3799.00\n\nSpeakers:&nbsp\;Aaron W
 inkler\, Immune Tolerance Lead and Research Fellow\, Inflammation and Imm
 unology\, Pfizer\, Adam Elhofy\, Vice President - Research and Collaborat
 ions\, COUR Pharmaceuticals\, Brian Zhou Associate\, Director - Immunolog
 y Venture Science\, Eli Lilly and Co.\, Caroline Gronwall\, Associate Pro
 fessor\, Karolinska Institutet\, Charlotte Fribert\, Chief Executive Offi
 cer\, Toleranzia\, Chris Tam\, CEO\, Integrated Nanotherapeutics\, Dan Sh
 elly\, Chief Business Officer\, PolTREG\, David Easterhoff\, Director\, M
 oderna\, Fiona McCann\, Associate Director - Pipeline Biology\, Immucore\
 , Geoffrey Lynn\, Senior Vice President - Synthetic Immunotherapies\, Bar
 inthus Biotherapeutics\, Jessica Kenison\, Director of Immunology\, Immun
 ocodex\, Joanne Tan\, Senior Vice President - R and D\, Parvus Therapeuti
 cs\, Joe Podojil\, Director - Immunology\, COUR Pharmaceuticals\, Jose Ca
 rballido\, Executive Director - Translational Medicine and Preclinical Sa
 fety\, Novartis\, Ken Howard\, Associate Professor\, Aarhus University\, 
 Kristie Grebe\, Chief Scientific Officer\, Anokion\, Lauren Higdon\, Dire
 ctor - Marker and Discovery Research\, Immune Tolerance Network\, Martina
  Sassone Corsi\, Associate Director - Discovery\, GentiBio\, Melissa Matz
 elle\, Associate Director - Immunology S and E\, Abbvie\, Michael Birnbau
 m\, Associate Professor - Biological Engineering\, Massachusetts Institut
 e of Technology\, Michael Birnbaum\, Associate Professor - Biological Eng
 ineering\, Massachusetts Institute of Technology\, Poul Sorensen\, Partne
 r and Entrepreneur-in-Residence\, ARGO Bio\, Tracey Lodie\, Chief Develop
 ment Officer\, GRO Bio\, Ulf Hannelius\, Chief Executive Officer\, Diamyd
  Medical\, Weston Daniel\, Chief Development Officer\, EVOQ Therapeutics\
 n\nCategory:&nbsp\;Conferences | Science\, Health and Medicine | Pharmace
 uticals\n\nDate and Time:&nbsp\;25th February 2025 at 8:00 am to 27th Feb
 ruary 2025 at 4:00 pm\n\nVenue details:&nbsp\;W Boston\, 100 Stuart Stree
 t\, Boston\, Massachusetts\, 02116\, United States\n
DTEND:20250227T160000
DTSTAMP:20260512T220334Z
DTSTART:20250225T080000
LOCATION:W Boston\, 100\, Stuart Street\, Boston\, Massachusetts\, 02116\,
SEQUENCE:0
SUMMARY:Immune tolerance offers a transformative approach to autoimmune di
 seases treatment and holds the power to modify the course of disease prog
 ression...
UID:26c2c69e-af3e-49c9-b812-c8680bba942b
END:VEVENT
END:VCALENDAR